Refine
Has Fulltext
- yes (222)
Is part of the Bibliography
- yes (222)
Year of publication
Document Type
- Journal article (222) (remove)
Keywords
- Chirurgie (27)
- Medizin (9)
- colorectal cancer (8)
- inflammation (8)
- obesity (8)
- Langerhans-Inseln (6)
- cytokines (6)
- Immunobiologie (5)
- Roux-en-Y gastric bypass surgery (4)
- Transplantation (4)
- bariatric surgery (4)
- inflammatory bowel disease (4)
- Antikörper (3)
- Schwein (3)
- Ureaplasma parvum (3)
- anastomotic leakage (3)
- chemotherapy (3)
- evidence-based medicine (3)
- guidelines (3)
- incisional hernia (3)
- indication for surgery (3)
- laparoscopic ventral hernia repair (3)
- liraglutide (3)
- open abdomen (3)
- parastomal hernia (3)
- perioperative management (3)
- sepsis (3)
- 5-Fluorouracil (2)
- Aspergillus (2)
- Bauchspeicheldrüse (2)
- COVID-19 (2)
- CRC (2)
- Crohn's disease (2)
- DNA damage (2)
- Germany (2)
- Ileum-Conduit (2)
- Immunbiologie (2)
- Inzisionalhernie (2)
- Krebs (2)
- Krebs <Medizin> (2)
- Modifizierte Sugarbaker-Technik (2)
- NAFLD (2)
- Parastomale Hernie (2)
- Pauli procedure (2)
- Pauli-Verfahren (2)
- Rectal cancer (2)
- Robotik (2)
- SARS-CoV-2 (2)
- Surgery (2)
- Trichternetz (IPST) (2)
- Umbilikalhernie (2)
- Ureaplasma urealyticum (2)
- abdominal trauma (2)
- adaptive immunity (2)
- adrenocortical carcinoma (2)
- animal model (2)
- antimicrobial stewardship (2)
- biomarker (2)
- cancer (2)
- case report (2)
- complication (2)
- desmosome (2)
- endoluminal (2)
- enzyme activation (2)
- enzyme inhibitors (2)
- funnel mesh (IPST) (2)
- gastric bypass (2)
- gastric cancer (2)
- giant ventral hernia (2)
- ileocecal resection (2)
- immunoassay (2)
- intestinal epithelial barrier (2)
- ischemia (2)
- islets of Langerhans (2)
- laparostomy (2)
- linea alba (2)
- malignant melanoma (2)
- meta-analysis (2)
- metastasis (2)
- microbial spectrum (2)
- modified Sugarbaker technique (2)
- mortality (2)
- negative pressure (2)
- oxaliplatin (2)
- pancreatic cancer (2)
- pediatric (2)
- peptide tyrosine tyrosine (PYY) (2)
- peritoneal carcinomatosis (2)
- phosphodiesterase (2)
- preterm infants (2)
- primary ventral hernia (2)
- primär ventrale Hernie (2)
- rat (2)
- rectum (2)
- skin (2)
- surgery (2)
- surgical therapy (2)
- swine (2)
- synthetic mesh (2)
- therapy (2)
- translational research (2)
- treatment (2)
- umbilical hernia (2)
- vacuum conditioning (2)
- vacuum-assisted closure (2)
- ventral hernia (2)
- 15-Deoxyspergualin (1)
- 1st-line treatment (1)
- 5-fluorouracil (1)
- 6-percent hydroxyethyl starch (1)
- AAA (1)
- ALCL (1)
- Abdominaltrauma (1)
- Activation (1)
- Adrenocortical Carcinoma (1)
- Allergie (1)
- Apoptosis (1)
- Attentional performance (1)
- Autologous (1)
- BM (1)
- Barrett-Ösophagus (1)
- Bauspeicheldrüse (1)
- Beta-catenin (1)
- Blood–brain barrier (1)
- Brain μ-opioid receptors (1)
- C-MYC (1)
- CA19-9 (1)
- CASP (1)
- CCR7 (1)
- CD62L (1)
- CNS integrity (1)
- COVID-19 pandemic (1)
- CX3CL1 (1)
- CX5461 (1)
- CXCL13 (1)
- Caco2 cells (1)
- Cancer (1)
- Carcinoma cells (1)
- Carcinomatosis (1)
- Central venous access (1)
- Central venous-pressure (1)
- Class II antigen blockade (1)
- Claudin2 (1)
- Cognitive (1)
- Coronary artery bypass graft (1)
- Coronavirus Disease 2019 (1)
- Critically-ill patients (1)
- Crohn’s Disease (1)
- Crohn’s disease (1)
- Cryolesion (1)
- Cushing (1)
- DNA repair (1)
- Damage control surgery (1)
- Danish hernia database (1)
- Diabetes (1)
- Dsg2 (1)
- Dünndarm (1)
- EDS (1)
- EHS classification (1)
- ERK (1)
- Ehlers-Danlos syndrome (1)
- Elective cesarean-section (1)
- Electrical impedance tomography (1)
- EndoVAC and small bowel (1)
- Epstein-Barr virus (1)
- Experimental brain trauma (1)
- Expression (1)
- Extra-anatomical (1)
- FWGE (1)
- Fascia transversalis (1)
- Femoral vein (1)
- Fibroblasts (1)
- Fluorouracil (1)
- Fn14 (1)
- GDNF5 (1)
- GIST (1)
- GLP-1 (1)
- General anaesthesia (1)
- Groin infection (1)
- Growth-factor receptor (1)
- Göttingen (1)
- HBMEC (1)
- Heterotransplantation (1)
- Hickman catheter (1)
- High-fat diet (1)
- Histologie (1)
- Hypertonic saline 7.5-percent (1)
- IL-6 (1)
- IVF-methods (1)
- Ileal conduit (1)
- Immunologie (1)
- Immunosenescence (1)
- Immunotherapy (1)
- Improved survival (1)
- In vitro models (1)
- Inhibition (1)
- Invasion (1)
- Inzisionale Hernie (1)
- Isolierung <Mikrobiologie> (1)
- KIT (1)
- Kollagenase (1)
- Kono-S anastomosis (1)
- LAMN (1)
- LND (1)
- LNE (1)
- Lactated ringers solution (1)
- Laparoscopy (1)
- Leistenhernie (1)
- Leptin (1)
- Lernkurve (1)
- Linea alba (1)
- Low-fat diet (1)
- LyP (1)
- Lymph nodes (1)
- MAPK pathway (1)
- MAPK signaling cascades (1)
- MHC Klasse II (1)
- MITF (1)
- MIZ1 (1)
- MPFL (1)
- MRI (1)
- MTL30 (1)
- MYC (1)
- Major abdominal surgery (1)
- Makrophage (1)
- Mammalian target (1)
- Matrix (1)
- Mesh Augmentation (1)
- Messerstichverletzung (1)
- Metastatic breast cancer (1)
- Mice (1)
- Minimalinvasiv (1)
- Minimalinvasive Leistenhernienversorgung (1)
- Minimally invasive surgery (1)
- Minischwein (1)
- Monoclonal antibody (1)
- Multicenter randomized-trial (1)
- NASH (1)
- NFκB (1)
- NPWT (1)
- Niere (1)
- Obturator bypass (1)
- Oncology (1)
- Organoids (1)
- P-glycoprotein (1)
- PCI (1)
- PCR (1)
- PDE (1)
- PDE4-I (1)
- PDGF (1)
- PET (1)
- PET imaging (1)
- PI-3-kinase (1)
- PI3K/Akt/mTOR (1)
- PLAG1 rearrangement (1)
- POEM (1)
- PYY3-36 (1)
- Pathway (1)
- Pediatric malignancy (1)
- Pharmakologie (1)
- Port (1)
- Posteriore Komponentenseparation (1)
- Postoperative complications (1)
- Predict fluid responsiveness (1)
- Primary hyperparathyroidism (pHPT) (1)
- Pulmonary function tests (1)
- Puls-pressure variation (1)
- RET6 (1)
- RNAPOL1 (1)
- RYGB (1)
- Radical prostatectomy (1)
- Radiochemotherapy (1)
- Randomized controlled-trial (1)
- Ratte (1)
- Regulatory T cells (1)
- Retromuskuläres Netz (1)
- Retrorektus Netz (1)
- Roux-en-Y gastric bypass (1)
- SSI (1)
- ST18 (1)
- Schussverletzung (1)
- Secondary traumatic brain damage (1)
- Serom (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- Surgical and invasive medical procedures (1)
- Surgical oncology (1)
- T cell receptors (1)
- T cells (1)
- TCR (1)
- TCR signaling cascade (1)
- TEER (1)
- TLR2 (1)
- TLR4 (1)
- TLR9 (1)
- TME (1)
- TNF (1)
- TREC (1)
- TWEAK (1)
- Telomere (1)
- Terroranschlagtrauma (1)
- Thrombosis (1)
- Time interval (1)
- Tissue (1)
- Toll-like receptor signaling (1)
- Transplantat (1)
- Up-regulation (1)
- V. saphena magna (1)
- VAC (1)
- VLBW (1)
- Ventrale Hernie (1)
- Y-gastric bypass (1)
- ZfKD (1)
- Zucker fatty fa/fa rats (1)
- [11C]-Choline PET/CT (1)
- [11C]-Methionine (1)
- [18F]FDG-PET-CT (1)
- [99mTc]-Sestamibi scan (1)
- abdominal compartment syndrome (1)
- abdominal lymph node metastases (1)
- abdominal surgery (1)
- abdominal wall hernia (1)
- abdominal wall surgery (1)
- accumulation (1)
- achalasia (1)
- acute (1)
- acute appendicitis (1)
- acute kidney injury (1)
- acute liver failure (1)
- acute respiratory distress syndrome (1)
- adipose-derived stromal/stem cells (ASCs) (1)
- adiposity (1)
- adjuvant (1)
- adrenal cancer (1)
- adrenal surgery (1)
- adrenal tumors (1)
- adrenalectomia (1)
- adrenocortical (1)
- adrenocortical adenocarcinoma (1)
- agonistic antibodies (1)
- alternative splicing (1)
- alveolar epithelium (1)
- anal atresia (1)
- anaplastic large cell lymphoma (1)
- anastomosis (1)
- anastomotic leak (1)
- anorectal abscess (1)
- anorectal angl (1)
- anorectal malformation (1)
- anti-tumor effects (1)
- antibiotic prescribing quality (1)
- antibiotic prescription behavior (1)
- antibiotic resistance (1)
- antibiotics (1)
- anticoagulation (1)
- antithrombotic therapy (1)
- appendectomy (1)
- appendicitis (1)
- appendix (1)
- assisted reproductive techniques (1)
- atrial fibrillation (1)
- autophagy (1)
- barrier models (1)
- benzoquinone (1)
- beta cells (1)
- biliopancreatic diversion (1)
- biological models (1)
- birth defects (1)
- bladder (1)
- blood (1)
- blood samples (1)
- blood-nerve barrier (1)
- blood–brain barrier (1)
- body fat (1)
- body mass index (BMI; kg/m\(^2\)) (1)
- body weight (1)
- bone marrow (1)
- brain metastases (1)
- brain plasticity (1)
- breast cancer (1)
- bridging (1)
- bronchopulmonary dysplasia (1)
- brown adipose tissue (1)
- bullae (1)
- burst abdomen (1)
- caco-2 cells (1)
- caloric-restriction (1)
- cancer cells (1)
- cancer diagnosis (1)
- cancer risk (1)
- cancer treatment (1)
- cancers and neoplasms (1)
- capture (1)
- carcinogenesis (1)
- carcinoma metastases to pancreas (1)
- carcinomas (1)
- cardiogenic (1)
- catheterization (1)
- catheters (1)
- cell cycle and cell division (1)
- cell death (1)
- cellular senescence (1)
- cerebEND (1)
- cerebral metastases (1)
- chemistry (1)
- chemokine receptor (1)
- children (1)
- children born (1)
- cholestasis (1)
- chylomicron (1)
- colloids (1)
- colon (1)
- colon cancer (1)
- colon carcinoma cells (1)
- colon resection (1)
- colorectal carcinoma (1)
- comet assay (1)
- complications (1)
- congenital malformations (1)
- conventional laparoscopic appendectomy (1)
- cord blood (1)
- cost-effectiveness (1)
- cotransporter SGLT1 (1)
- creatinine (1)
- curative resection (1)
- cytostatic (1)
- cytotoxicity (1)
- damage control surgery (1)
- dass II antigen blockade (1)
- deconstruction into key steps (1)
- definition (1)
- dendritic cells (1)
- descriptive epidemiology (1)
- desmoglein (1)
- dexamethasone (1)
- diabetes (1)
- diagnosis (1)
- diagnostics (1)
- discharge definition (1)
- drug-eluting beads (1)
- dual-room whole-body CT (1)
- duodenal jejunal bypass (1)
- duodenal perforation (1)
- duodenal trauma (1)
- elective surgery (1)
- endoscopic (1)
- endoscopic full thickness resection (eFTR) (1)
- endoscopic groin hernia repair (1)
- endosponge (1)
- endotoxemia (1)
- endovascular repair (1)
- energy homeostasis (1)
- enteric glial cells (1)
- enteric nervous system (1)
- ephitelial cells (1)
- epidemiology (1)
- epidural block (1)
- epigastric hernia (1)
- epithelial cells (1)
- epithelium (1)
- esophageal perforation (1)
- expenditure (1)
- experimental models of disease (1)
- experimental therapy (1)
- extracorporeal membrane oxygenation (1)
- extremity trauma (1)
- fascial closure (1)
- fat absorption (1)
- fat appetite (1)
- fatty liver (1)
- femoral hernia (1)
- fish bone (1)
- fistulizing Crohn’s Disease (1)
- flow cytometry (1)
- focused surgical approach (1)
- folinic acid (1)
- food intake (1)
- foreign body ingestion (1)
- fracture-associated vascular damage (1)
- full-thickness resection device (FTRD) (1)
- gastric-bypass surgery (1)
- gastrointestinal infections (1)
- gastrointestinal perforation (1)
- gastrointestinal tract (1)
- gemcitabine (1)
- gene regulation (1)
- generation (1)
- geriatric (1)
- germline mutation (1)
- glucagon like peptide-1 (1)
- glucocorticoid receptor (1)
- glucose homeostasis (1)
- glucose metabolism (1)
- glucose starvation (1)
- groin hernia (1)
- growth differentiation factor 15 (1)
- gut barrier (1)
- gut hormones (1)
- hematology (1)
- hemorrhagic (1)
- henoch-schönlein purpura (1)
- hepatic resection (1)
- hepatocellular carcinoma (1)
- hernia (1)
- hernia defect (1)
- hernia repair material (1)
- histologic diversity (1)
- histopathology (1)
- human biomonitoring (1)
- human cancer (1)
- human melanoma (1)
- hypersensitivity (1)
- hypothalamic gene expression (1)
- hypoxia (1)
- idiopathic fecal incontinence (1)
- ileal conduit (1)
- imaging (1)
- immaturity (1)
- immune check inhibitor (1)
- immune response (1)
- immunity (1)
- immunosuppression (1)
- immunotherapeutics (1)
- impedance spectroscopy (1)
- imperforate anus (1)
- in vitro model (1)
- in vivo (1)
- in-vitro fertilization (1)
- incisional abdominal wall hernia (1)
- induced obesity (1)
- infants born (1)
- inflammation-induced tissue demage (1)
- inguinal hernia (1)
- inguinal lymph node dissection (1)
- insulin resistance (1)
- intercellular junctions (1)
- intestinal barrier (1)
- intestinal glucose (1)
- intestinal microbiota (1)
- intestine (1)
- intraabdominal abscess (1)
- intragastric balloon (1)
- intravenous glucose tolerance test (1)
- inzisionale Hernie (1)
- ionizing radiation (1)
- irinotecan (1)
- islet transplantation (1)
- isocaloric intake (1)
- isosteviol sodium (STVNA) (1)
- kappa-B (1)
- ketogenic dients (1)
- ketogenic diet (1)
- ketone bodies (1)
- kidney (1)
- kidneys (1)
- la antigens (1)
- laparoscopic appendectomy (1)
- laparoscopic course (1)
- laparoscopic right colectomy (1)
- laparoscopic skills (1)
- laparoscopy (1)
- late onset sepsis (1)
- learning curve (1)
- left hemicolectomy (1)
- leptin (1)
- leptin system (1)
- leukemia (1)
- level of evidence: IV (1)
- lipoblastoma (1)
- lipodystrophy (1)
- liver resection (1)
- locally advanced disease (1)
- low molecular heparin (1)
- low-grade mucinous neoplasm (1)
- low-risk intra-abdominal infections (1)
- lung resection (1)
- lymph node dissection (1)
- lymph nodes (1)
- lymphadenectomy (1)
- lymphomatoid papulosis (1)
- magnetic resonance imaging (1)
- maintain immune homeostasis (1)
- management (1)
- mass (1)
- mastocytosis (1)
- measles virus (1)
- medial patellofemoral ligament (1)
- meningitis (1)
- mesenchymal stem cells (1)
- mesh augmentation (1)
- mesh repair (1)
- metaanalysis (1)
- metabolic profile (1)
- metabolically unhealthy obesity (1)
- metabolism (1)
- metachronous (1)
- miRNA expression (1)
- mice (1)
- microbiota (1)
- minimalinvasiv (1)
- minimally invasive (1)
- mold exposure (1)
- molecular diagnostics (1)
- monocyte subsets (1)
- monocytes (1)
- mortality rate (1)
- mucormycosis (1)
- mucosal healing (MH) (1)
- multimodal (1)
- myeloid (1)
- nab-paclitaxel (1)
- negative pressure wound therapy (1)
- neoadjuvant (1)
- neoadjuvant chemotherapy (1)
- neonatal immunology (1)
- neonatal meningitis (1)
- neonatal outcome (1)
- netrin-1 (1)
- neuroblastoma – diagnosis (1)
- neuroendocrine tumor (NET) (1)
- neuroinflammation (1)
- neuropathic pain (1)
- neurotrophic factors (1)
- noradrenaline (1)
- noradrenaline transporter (1)
- obesity surgery (1)
- octogenarians (1)
- octogenerians (1)
- older adult (1)
- oncogene-induced senescence (1)
- open appendectomy (1)
- open wound treatment (1)
- operative (1)
- oral anticoagulants (1)
- organoid (1)
- outcome (1)
- pancreas Islets (1)
- pancreatectomy (1)
- pancreatic adenocarcinoma (PDAC) (1)
- pancreatic head cancer (1)
- parathyroid adenoma (1)
- parathyroid carcinoma (1)
- patella alta (1)
- patella dislocation (1)
- patella instability (1)
- pathway analysis (1)
- patient-derived organoid (PDOs) (1)
- patient-derived tumor organoid (PDTO) (1)
- pediatric adrenocortical adenoma (1)
- pediatric adrenocortical cancer (1)
- pediatric adrenocortical tumor (1)
- pelvic trauma (1)
- pembrolizumab (1)
- pemphigus (1)
- penetrating ileitis (1)
- peptide tyrosine tyrosine 3-36 (PYY3-36) (1)
- peptide tyrosine tyrosine 3-36 (PYY\(_{3-36}\)) (1)
- perianal fistulas (1)
- perioperative antibiotic prophylaxis (1)
- perioperative chemotherapy (1)
- periphery-brain interactions (1)
- peritonitis (1)
- permeability (1)
- peroral endoscopic myotomy (1)
- phosphodiesterase-4 (1)
- phosphodiesterase-inhibitors (1)
- pig or swine (1)
- platelet dysfunction (1)
- popliteal aneurysm (1)
- positron emission tomography imaging (1)
- post-operative antibiotic treatment (1)
- posterior component separation (1)
- posteriore Komponentenseparation (1)
- postoperative bleeding (1)
- postoperative inflammation (1)
- preclinical research (1)
- preoperative localization (1)
- preterm birth (1)
- prevalence (1)
- primary hyperparathyroidism (1)
- prognosis (1)
- prognostic factors (1)
- prospective studies (1)
- protein expression (1)
- protein kinase D2/PKD2/PRKD2 (1)
- protein synthesis (1)
- quality of life (1)
- r-TAPP (1)
- radiotracer (1)
- reactivating p53 and inducing tumor apoptosis (RITA) (1)
- reactive oxygen (1)
- reactive oxygen species (1)
- real-time glucose monitoring (1)
- rectal cancer (1)
- rectal resection (1)
- recurrence survival (1)
- recurrent abdominal wall hernia (1)
- regeneration (1)
- regenerative medicine (1)
- regional recurrence (1)
- regionalization and organoids (1)
- registries (1)
- regulatory T cells (1)
- renal transplantation (1)
- repeat surgery (1)
- repeated surgery (1)
- reproductive medicine (1)
- resuscitation time (1)
- retromuscular mesh (1)
- retromuskuläres Netz (1)
- retroperitoneal tumor (1)
- retrorectus mesh (1)
- retrorektus Netz (1)
- retrospective study (1)
- reverse transcriptase-polymerase chain reaction (1)
- review (1)
- ribosome (1)
- risk factor (1)
- risk factors (1)
- robotic surgery (1)
- robotic surgical procedures (1)
- robotische Leistenhernienversorgung (1)
- rolipram (1)
- rygb (1)
- sacral nerve stimulation (1)
- sacral neuromodulation (1)
- screening (1)
- seahorse (1)
- secondary skin closure (1)
- secretion (1)
- seminoma (1)
- septic (1)
- seroma (1)
- serotonin (1)
- serotonin transporter (1)
- shock (1)
- shooting injuries (1)
- single-port appendectomy (1)
- sleeve gastrectomy (1)
- small bowel (1)
- small interferring RNA (1)
- stab wounds (1)
- streptozotocin (1)
- super-obesity (1)
- superior (1)
- surgical (1)
- surgical and invasive medical procedures (1)
- surgical care (1)
- surgical complications (1)
- surgical intra-abdominal infections (1)
- surgical management (1)
- surgical oncology (1)
- surgical outcome (1)
- surgical procedures (1)
- surgical resection (1)
- surgical site infection (1)
- surgical site infections (1)
- surgical trauma room (1)
- surgical treatment (1)
- survival (1)
- survival analysis (1)
- sympathetic nervous system (1)
- systematic review (1)
- systemic and cutaneous CD30+ lymphoproliferations (1)
- systemic endotoxemia (1)
- teaching methods (1)
- technology (1)
- terminal ileitis (1)
- terror attack trauma (1)
- thermogenesis (1)
- thromboembolism (1)
- thyroid gland (1)
- thyroiditis (1)
- tight junction (1)
- tight junction proteins (1)
- tissue (1)
- tolerance (1)
- total pancreatectomy (1)
- transanal endoscopic microsurgery (TEM) (1)
- transarterial chemoembolization (1)
- translation initiation (1)
- transplant (1)
- transplantation (1)
- transstomal endoluminal vacuum therapy (1)
- transverse fascia (1)
- trauma centre (1)
- trauma management (1)
- trochlear dysplasia (1)
- trophic factors (1)
- tumor disease (1)
- tumor growth (1)
- type 2 diabetes (1)
- uncoupling protein 1 (1)
- urinary tract infections (1)
- urine (1)
- vascular type (1)
- vasculitis (1)
- ventral hernia model (1)
- ventrale Hernie (1)
- visceral fat (1)
- vitamin D (1)
- volume (1)
- warfarin interruption (1)
- weight-gain (1)
- wound infection (1)
- xenogeneic transplantation (1)
- xenogenic transplantation (1)
- β-Hydroxybutyrate (1)
Institute
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (222) (remove)
Sonstige beteiligte Institutionen
Background:
Ketogenic diets (KDs) or short-term fasting are popular trends amongst supportive approaches for cancer patients. Beta-hydroxybutyrate (3-OHB) is the main physiological ketone body, whose concentration can reach plasma levels of 2–6 mM during KDs or fasting. The impact of 3-OHB on the biology of tumor cells described so far is contradictory. Therefore, we investigated the effect of a physiological concentration of 3 mM 3-OHB on metabolism, proliferation, and viability of breast cancer (BC) cells in vitro.
Methods:
Seven different human BC cell lines (BT20, BT474, HBL100, MCF-7, MDA-MB 231, MDA-MB 468, and T47D) were cultured in medium with 5 mM glucose in the presence of 3 mM 3-OHB at mild hypoxia (5% oxygen) or normoxia (21% oxygen). Metabolic profiling was performed by quantification of the turnover of glucose, lactate, and 3-OHB and by Seahorse metabolic flux analysis. Expression of key enzymes of ketolysis as well as the main monocarboxylic acid transporter MCT2 and the glucose-transporter GLUT1 was analyzed by RT-qPCR and Western blotting. The effect of 3-OHB on short- and long-term cell proliferation as well as chemo- and radiosensitivity were also analyzed.
Results:
3-OHB significantly changed the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in BT20 cells resulting in a more oxidative energetic phenotype. MCF-7 and MDA-MB 468 cells had increased ECAR only in response to 3-OHB, while the other three cell types remained uninfluenced. All cells expressed MCT2 and GLUT1, thus being able to uptake the metabolites. The consumption of 3-OHB was not strongly linked to mRNA overexpression of key enzymes of ketolysis and did not correlate with lactate production and glucose consumption. Neither 3-OHB nor acetoacetate did interfere with proliferation. Further, 3-OHB incubation did not modify the response of the tested BC cell lines to chemotherapy or radiation.
Conclusions:
We found that a physiological level of 3-OHB can change the energetic profile of some BC cell lines. However, 3-OHB failed to influence different biologic processes in these cells, e.g., cell proliferation and the response to common breast cancer chemotherapy and radiotherapy. Thus, we have no evidence that 3-OHB generally influences the biology of breast cancer cells in vitro.
Peroral endoscopic myotomy (POEM) is a new endoscopic treatment for achalasia with very good short-term results in adults. Data about POEM in pediatric patients are missing. We present the case of a 10-year-old male patient with type I (classic) achalasia, successfully treated with POEM. The procedure was accomplished in a similar fashion to the technique used in adults. Short-term results were fine, with a complete control of dysphagia and absence of reflux. We suggest that POEM is a suitable option in pediatric patients—similar to adults—but long-term results must be awaited.
Objective: To investigate the impact of the phophodiesterase-4 inhibition (PD-4-I) with rolipram on hepatic integrity in lipopolysaccharide (LPS) induced hyperinflammation. Materials and Methods: Liver microcirculation in rats was obtained using intravital microscopy. Macrohemodynamic parameters, blood assays, and organs were harvested to determine organ function and injury. Hyperinflammation was induced by LPS and PD-4-I rolipram was administered intravenously one hour after LPS application. Cell viability of HepG2 cells was measured by EZ4U-kit based on the dye XTT. Experiments were carried out assessing the influence of different concentrations of tumor necrosis factor alpha (TNF-α) and LPS with or without PD-4-I. Results: Untreated LPS-induced rats showed significantly decreased liver microcirculation and increased hepatic cell death, whereas LPS + PD-4-I treatment could improve hepatic volumetric flow and cell death to control level whithout influencing the inflammatory impact. In HepG2 cells TNF-α and LPS significantly reduced cell viability. Coincubation with PD-4-I increased HepG2 viability to control levels. The heme oxygenase 1 (HO-1) pathway did not induce the protective effect of PD-4-I. Conclusion: Intravenous PD-4-I treatment was effective in improving hepatic microcirculation and hepatic integrity, while it had a direct protective effect on HepG2 viability during inflammation.
Bariatric operations in obese patients with type 2 diabetes often improve diabetes before weight loss is observed. In patients mainly Roux-en-Y-gastric bypass with partial stomach resection is performed. Duodenojejunal bypass (DJB) and ileal interposition (IIP) are employed in animal experiments. Due to increased glucose exposition of L-cells located in distal ileum, all bariatric surgery procedures lead to higher secretion of antidiabetic glucagon like peptide-1 (GLP-1) after glucose gavage. After DJB also downregulation of Na\(^{+}\)-D-glucose cotransporter SGLT1 was observed. This suggested a direct contribution of decreased glucose absorption to the antidiabetic effect of bariatric surgery. To investigate whether glucose absorption is also decreased after IIP, we induced diabetes with decreased glucose tolerance and insulin sensitivity in male rats and investigated effects of IIP on diabetes and SGLT1. After IIP, we observed weight-independent improvement of glucose tolerance, increased insulin sensitivity, and increased plasma GLP-1 after glucose gavage. The interposed ileum was increased in diameter and showed increased length of villi, hyperplasia of the epithelial layer, and increased number of L-cells. The amount of SGLT1-mediated glucose uptake in interposed ileum was increased 2-fold reaching the same level as in jejunum. Thus, improvement of glycemic control by bariatric surgery does not require decreased glucose absorption.
Background:
Single drug use has not achieved satisfactory results in the treatment of prostate cancer, despite application of increasingly widespread targeted therapeutics. In the present study, the combined impact of the mammalian target of rapamycin (mTOR)-inhibitor RAD001, the dual EGFr and VGEFr tyrosine kinase inhibitor AEE788 and the histone deacetylase (HDAC)-inhibitor valproic acid (VPA) on prostate cancer growth and adhesion in vitro was investigated.
Methods:
PC-3, DU-145 and LNCaP cells were treated with RAD001, AEE788 or VPA or with a RAD-AEE-VPA combination. Tumor cell growth, cell cycle progression and cell cycle regulating proteins were then investigated by MTT-assay, flow cytometry and western blotting, respectively. Furthermore, tumor cell adhesion to vascular endothelium or to immobilized extracellular matrix proteins as well as migratory properties of the cells was evaluated, and integrin alpha and beta subtypes were analyzed. Finally, effects of drug treatment on cell signaling pathways were determined.
Results:
All drugs, separately applied, reduced tumor cell adhesion, migration and growth. A much stronger anticancer effect was evoked by the triple drug combination. Particularly, cdk1, 2 and 4 and cyclin B were reduced, whereas p27 was elevated. In addition, simultaneous application of RAD001, AEE788 and VPA altered the membranous, cytoplasmic and gene expression pattern of various integrin alpha and beta subtypes, reduced integrin-linked kinase (ILK) and deactivated focal adhesion kinase (FAK). Signaling analysis revealed that EGFr and the downstream target Akt, as well as p70S6k was distinctly modified in the presence of the drug combination.
Conclusions:
Simultaneous targeting of several key proteins in prostate cancer cells provides an advantage over targeting a single pathway. Since strong anti-tumor properties became evident with respect to cell growth and adhesion dynamics, the triple drug combination might provide progress in the treatment of advanced prostate cancer.
In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells
(2015)
Oncogenic signaling in melanocytes results in oncogene-induced senescence (OIS), a stable cell-cycle arrest frequently characterized by a bi-or multinuclear phenotype that is considered as a barrier to cancer progression. However, the long-sustained conviction that senescence is a truly irreversible process has recently been challenged. Still, it is not known whether cells driven into OIS can progress to cancer and thereby pose a potential threat. Here, we show that prolonged expression of the melanoma oncogene N-RAS\(^{61K}\) in pigment cells overcomes OIS by triggering the emergence of tumor-initiating mononucleated stem-like cells from senescent cells. This progeny is dedifferentiated, highly proliferative, anoikis-resistant and induces fast growing, metastatic tumors. Our data describe that differentiated cells, which are driven into senescence by an oncogene, use this senescence state as trigger for tumor transformation, giving rise to highly aggressive tumor-initiating cells. These observations provide the first experimental in vitro evidence for the evasion of OIS on the cellular level and ensuing transformation.
Toll like receptor (TLR) signaling has been suggested to play an important role in the inflammatory microenvironment of solid tumors and through this inflammation-mediated tumor growth. Here, we studied the role of tumor cells in their process of self-maintaining TLR expression independent of inflammatory cells and cytokine milieu for autoregulative tumor growth signaling in pancreatic cancer. We analyzed the expression of TLR2, -4, and -9 in primary human cancers and their impact on tumor growth via induced activation in several established pancreatic cancers. TLR-stimulated pancreatic cancer cells were specifically investigated for activated signaling pathways of VEGF/PDGF and anti-apoptotic Bcl-xL expression as well as tumor cell growth. The primary pancreatic cancers and cell lines expressed TLR2, -4, and -9. TLR-specific stimulation resulted in activated MAP-kinase signaling, most likely via autoregulative stimulation of demonstrated TLR-induced VEGF and PDGF expression. Moreover, TLR activation prompted the expression of Bcl-xL and has been demonstrated for the first time to induce tumor cell proliferation in pancreatic cancer. These findings strongly suggest that pancreatic cancer cells use specific Toll like receptor signaling to promote tumor cell proliferation and emphasize the particular role of TLR2, -4, and -9 in this autoregulative process of tumor cell activation and proliferation in pancreatic cancer.
Introduction:
During damage control surgery for blunt abdominal traumata simultaneous duodenal perforations can be missed making secondary sufficient surgical treatment challenging. Endoluminal vacuum (EndoVAC™) therapy has been shown to be a revolutionary option but has anatomical and technical limits.
Presentation of the case:
A 59-year old man with hemorrhagic shock due to rupture of the mesenteric root after blunt abdominal trauma received damage control treatment. Within a scheduled second-look, perforation of the posterior duodenal wall was identified. Due to local and systemic conditions, further surgical treatment was limited. Decision for endoscopic treatment was made but proved to be difficult due to the distal location. Finally, double-barreled jejunal stoma was created for transstomal EndoVAC™ treatment. Complete leakage healing was achieved and jejunostomy reversal followed subsequently.
Discussion:
During damage control surgery simultaneous bowel injuries can be missed leading to life-threatening complications with limited surgical options. EndoVAC™ treatment is an option for gastrointestinal perforations but has anatomical limitations that can be sufficiently shifted by a transstomal approach for intestinal leakage.
Conclusion:
In trauma related laparotomy complete mobilization of the duodenum is crucial. As ultima ratio, transstomal EndoVAC™ is a safe and feasible option and can be considered for similar cases.
Background:
Metastatic Adrenocortical Carcinoma (ACC) is a rare malignancy with a poor 5-year-survival rate (<15%). A surgical approach is recommended in selected patients if complete resection of distant metastasis can be achieved. To date there are only limited data on the outcome after surgical resection of hepatic metastases of ACC.
Methods:
A retrospective analysis of the German Adrenocortical Carcinoma Registry was conducted. Patients with liver metastases of ACC but without extrahepatic metastases or incomplete tumour resection were included.
Results:
Seventy-seven patients fulfilled these criteria. Forty-three patients underwent resection of liver metastases of ACC. Complete tumour resection (R0) could be achieved in 30 (69.8%). Median overall survival after liver resection was 76.1 months in comparison to 10.1 months in the 34 remaining patients with unresected liver metastases (p < 0.001). However, disease free survival after liver resection was only 9.1 months. Neither resection status (R0/R1) nor extent of liver resection were significant predictive factors for overall survival. Patients with a time interval to the first metastasis/recurrence (TTFR) of greater than 12 months or solitary liver metastases showed significantly prolonged survival.
Conclusions:
Liver resection in the case of ACC liver metastases can achieve long term survival with a median overall survival of more than 5 years, but disease free survival is short despite metastasectomy. Time to recurrence and single versus multiple metastases are predictive factors for the outcome.
Background:
The use of venoarterial extracorporeal membrane oxygenation (va-ECMO) via peripheral cannulation for septic shock is limited by blood flow and increased afterload for the left ventricle.
Case Report:
A 15-year-old girl with acute myelogenous leukemia, suffering from severe septic and cardiogenic shock, was treated by venoarterial extracorporeal membrane oxygenation (va-ECMO). Sufficient extracorporeal blood flow matching the required oxygen demand could only be achieved by peripheral cannulation of both femoral arteries. Venous drainage was performed with a bicaval cannula inserted via the left V. femoralis. To accomplish left ventricular unloading, an additional drainage cannula was placed in the left atrium via percutaneous atrioseptostomy (va-va-ECMO). Cardiac function recovered and the girl was weaned from the ECMO on day 6. Successful allogenic stem cell transplantation took place 2 months later.
Conclusions:
In patients with vasoplegic septic shock and impaired cardiac contractility, double peripheral venoarterial extracorporeal membrane oxygenation (va-va-ECMO) with transseptal left atrial venting can by a lifesaving option.